Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
368.92
+0.50 (0.14%)
Nov 4, 2024, 4:00 PM EST - Market closed

Bio-Rad Laboratories Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for BIO stock have an average target of 398.5, with a low estimate of 340 and a high estimate of 469. The average target predicts an increase of 8.02% from the current stock price of 368.92.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $340 $398.5 $400 $469
Change -7.84% +8.02% +8.42% +27.13%

Analyst Ratings

The average analyst rating for BIO stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 111112
Buy 111111
Hold 111221
Sell 000000
Strong Sell 000000
Total 333444

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Buy
Maintains
$446$469
Buy Maintains $446$469 +27.13% Oct 31, 2024
Citigroup
Citigroup
Strong Buy
Upgrades
$350$400
Strong Buy Upgrades $350$400 +8.42% Oct 1, 2024
Wells Fargo
Wells Fargo
Hold
Initiates
$340
Hold Initiates $340 -7.84% Aug 27, 2024
RBC Capital
RBC Capital
Buy
Reiterates
$401
Buy Reiterates $401 +8.70% Aug 16, 2024
RBC Capital
RBC Capital
Buy
Maintains
$402$401
Buy Maintains $402$401 +8.70% Aug 2, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
2.60B
from 2.67B
Decreased by -2.63%
Revenue Next Year
2.72B
from 2.60B
Increased by 4.42%
EPS This Year
9.47
from -21.82
EPS Next Year
11.12
from 9.47
Increased by 17.42%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
2.31B2.55B2.92B2.80B2.67B2.60B2.72B2.84B
Revenue Growth
0.97%10.12%14.81%-4.12%-4.67%-2.63%4.42%4.38%
EPS
58.27126.47140.83-121.79-21.829.4711.1212.47
EPS Growth
381.57%117.04%11.35%---17.42%12.15%
Forward PE
-----38.9733.1929.59
No. Analysts -----997
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 2.7B 2.9B 3.0B
Avg 2.6B 2.7B 2.8B
Low 2.5B 2.6B 2.7B

Revenue Growth

Revenue Growth 20242025202620272028
High
1.9%
9.7%
9.9%
Avg
-2.6%
4.4%
4.4%
Low
-6.0%
-0.0%
-0.5%

EPS Forecast

EPS 20242025202620272028
High 10.79 12.30 13.76
Avg 9.47 11.12 12.47
Low 8.69 9.93 11.12

EPS Growth

EPS Growth 20242025202620272028
High -
29.9%
23.7%
Avg -
17.4%
12.2%
Low -
4.9%
0.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.